Kathryn Anastos, MD; Yolanda Barrón, MS; Mardge H. Cohen, MD; Ruth M. Greenblatt, MD; Howard Minkoff, MD; Alexandra Levine, MD; Mary Young, MD; Stephen J. Gange, PhD
Grant Support: The WIHS is funded by the National Institute of Allergy and Infectious Diseases with supplemental funding from the National Cancer Institute, the National Institute on Drug Abuse, and the National Institute of Dental Research (grants U01-AI-35004, U01-AI-31834, U01-AI-34994, U01-AI-34989, U01-AI-34993, and U01-AI-42590). Funding was also provided by the National Institute of Child Health and Human Development (grant U01-HD-32632) and the National Center for Research Resources (grants M01-RR-00071, M01-RR-00079, and M01-RR00083).
Potential Financial Conflicts of Interest: None disclosed.
Requests for Single Reprints: Kathryn Anastos, MD, Women's Interagency HIV Study, 3311 Bainbridge Avenue, Second Floor, Bronx, NY 10467; e-mail, firstname.lastname@example.org.
Current Author Addresses: Dr. Anastos: WIHS, Montefiore Medical Center, 3311 Bainbridge Avenue, Bronx, NY 10467.
Ms. Barrón: Department of Epidemiology, Johns Hopkins University Bloomberg School of Public of Health, 615 North Wolfe Street/Room E7012, Baltimore, MD 21205.
Dr. Cohen: Core Center, Cook County Bureau of Health Services, 2020 W. Harrison, Chicago, IL 60612.
Dr. Greenblatt: Infectious Diseases Division, Box 1352, University of California, San Francisco, San Francisco, CA 94143-1352.
Dr. Minkoff: Maimonides Medical Center, 967 48th Street, Brooklyn, NY 11219.
Dr. Levine: Division of Hematology, USC/Norris Cancer Hospital, 1441 Eastlake Avenue, Room 3468, Los Angeles, CA 90033.
Dr. Young: Georgetown University Medical Center, 110 Kober-Cogan Building, 3800 Reservoir Road, NW, Washington, DC 20007.
Dr. Gange: Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320-1799.
Author Contributions: Conception and design: K. Anastos, M.H. Cohen, R.M. Greenblatt, A. Levine, S.J. Gange.
Analysis and interpretation of the data: K. Anastos, Y. Barrón, M.H. Cohen, S.J. Gange.
Drafting of the article: K. Anastos, Y. Barrón, R.M. Greenblatt, A. Levine, S.J. Gange.
Critical revision of the article for important intellectual content: K. Anastos, Y. Barrón, M.H. Cohen, R.M. Greenblatt, H. Minkoff, A. Levine, M. Young, S.J. Gange.
Final approval of the article: K. Anastos, Y. Barrón, M.H. Cohen, R.M. Greenblatt, H. Minkoff, A. Levine, M. Young, S.J. Gange.
Provision of the study materials or patients: K. Anastos, M.H. Cohen, R.M. Greenblatt, H. Minkoff, A. Levine, M. Young.
Statistical expertise: Y. Barrón, S.J. Gange.
Obtaining of funding: K. Anastos, M.H. Cohen, R.M. Greenblatt, H. Minkoff, A. Levine, M. Young, S.J. Gange.
Administrative, technical, or logistic support: K. Anastos.
Collection and assembly of the data: K. Anastos, M.H. Cohen, R.M. Greenblatt, S.J. Gange.
Anastos K, Barrón Y, Cohen MH, Greenblatt RM, Minkoff H, Levine A, et al. The Prognostic Importance of Changes in CD4+Cell Count and HIV-1 RNA Level in Women after Initiating Highly Active Antiretroviral Therapy. Ann Intern Med. 2004;140:256-264. doi: 10.7326/0003-4819-140-4-200402170-00007
Download citation file:
Published: Ann Intern Med. 2004;140(4):256-264.
Learn more about subscription options.
Register Now for a free account.
Infectious Disease, HIV.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only